Hindustan Bio Sciences Limited (BOM:532041)

India flag India · Delayed Price · Currency is INR
9.21
0.00 (0.00%)
At close: Apr 28, 2026
16.73%
Market Cap 94.41M
Revenue (ttm) 11.35M
Net Income (ttm) 1.48M
Shares Out 10.25M
EPS (ttm) 0.16
PE Ratio 59.16
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,011
Average Volume 9,047
Open 9.39
Previous Close 9.21
Day's Range 8.81 - 9.65
52-Week Range 5.00 - 10.32
Beta -0.91
RSI 58.87
Earnings Date May 29, 2026

About Hindustan Bio Sciences

Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology product, recombinant human Erythropotien; and trading of drugs and medicines. In addition, the company exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1991
Employees 2
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532041
Full Company Profile

Financial Performance

In fiscal year 2025, Hindustan Bio Sciences's revenue was 8.13 million, a decrease of -22.75% compared to the previous year's 10.53 million. Earnings were 1.01 million, an increase of 74.83%.

Financial Statements

News

There is no news available yet.